Psychedelics as a Treatment for Alzheimer’s Disease Dementia: Reviewing Their Potential as Disease-Modifying Therapies

There are currently no disease-modifying treatments for Alzheimer’s disease or other dementia subtypes. The supplied metadata identifies a review of the renewed interest in psychedelic research and its potential relevance to Alzheimer’s disease dementia. The source does not provide the article’s detailed arguments, evidence, specific psychedelic compounds, study findings, mechanisms, limitations, or clinical recommendations. Accordingly, the central supported subject is the investigation of psychedelics as a possible treatment strategy for Alzheimer’s disease dementia, within a broader clinical and research context. The available material is insufficient to determine whether the article presents preclinical evidence, clinical evidence, or a firm therapeutic conclusion.